Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index F

Face
pain in: Sec. 3, Ch. 29
rosacea of: Sec. 3, Ch. 35; Sec. 3, Ch. 35
seborrheic dermatitis of: Sec. 3, Ch. 35
shingles of: Sec. 3, Ch. 35
Factor V Leiden mutation: Sec. 3, Ch. 49
Failure to thrive: Sec. 3, Ch. 17
Fainting: Sec. 3, Ch. 20
in abnormal heart rhythms: Sec. 3, Ch. 47
Falls: Sec. 3, Ch. 21
during hospitalization: Sec. 2, Ch. 11
in Parkinson's disease: Sec. 3, Ch. 30
prevention of: Sec. 2, Ch. 11; Sec. 3, Ch. 21; Sec. 3, Ch. 23
undernutrition and: Sec. 3, Ch. 17
False-negative test result: Sec. 2, Ch. 10
False-positive test result: Sec. 2, Ch. 10
Family Medical Leave Act: Sec. 2, Ch. 15
Family practice doctor: Sec. 2, Ch. 9
Family
intimacy and: Sec. 4, Ch. 63
Famotidine: Sec. 2, Ch. 6
Fasciitis
plantar: Sec. 3, Ch. 40
Fat
body
     estimate of: Sec. 2, Ch. 5; Sec. 3, Ch. 17
     increase in: (see also Obesity); Sec. 3, Ch. 17; Sec. 1, Ch. 2
dietary: Sec. 2, Ch. 4; Sec. 2, Ch. 5
subcutaneous: Sec. 3 Ch. 35 [detail]; Sec. 3, Ch. 35; Sec. 1, Ch. 2
Fatigue
at end of life: Sec. 2, Ch. 16
in cancer: Sec. 3, Ch. 50
Fatty acids
trans: Sec. 2, Ch. 5; Sec. 2, Ch. 5
Fear: Sec. 1, Ch. 1
Fecal incontinence: Sec. 3, Ch. 55
in colorectal cancer: Sec. 3, Ch. 51
during hospitalization: Sec. 2, Ch. 11
pressure sores and: Sec. 3, Ch. 35
Feces: (see Stool)
Feeding
intravenous: Sec. 3, Ch. 17
tube: Sec. 3, Ch. 17; Sec. 2, Ch. 11; Sec. 2, Ch. 12
in undernutrition: Sec. 2, Ch. 11; Sec. 3, Ch. 17
Felodipine
in coronary artery disease: Sec. 3, Ch. 45
in high blood pressure: Sec. 3, Ch. 43
Felty's syndrome: Sec. 3, Ch. 41
Femoral artery: Sec. 3, Ch. 44
Fenofibrate: Sec. 3, Ch. 44
Fertility
Floaters: Sec. 1, Ch. 2
function and: Sec. 1, Ch. 1
male: Sec. 1, Ch. 2
of older Americans: Sec. 1, Ch. 3
Fever: Sec. 3, Ch. 19
in influenza: Sec. 3, Ch. 52
in urinary tract infection: Sec. 3, Ch. 56
Feverfew: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7
Fiber
dietary: Sec. 2, Ch. 5; Sec. 3, Ch. 44
     in constipation: Sec. 3, Ch. 55; Sec. 3, Ch. 55
Fibric acid derivatives: Sec. 3, Ch. 44
Fibroids
uterine: Sec. 3, Ch. 58; Sec. 3, Ch. 58
Fibrosis
bone marrow: Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3 Ch. 49 [sidebar]
pulmonary: Sec. 3 Ch. 46 [detail]
Fillings
dental: Sec. 3, Ch. 39
Filter
for blood clots: Sec. 3, Ch. 44; Sec. 3, Ch. 44
Finances
health care: Sec. 4, Ch. 66
home health care and: Sec. 2, Ch. 5; Sec. 2, Ch. 15
relationships and: Sec. 4, Ch. 63
Financial abuse: Sec. 4, Ch. 64
Finasteride
in benign prostatic hyperplasia: Sec. 3, Ch. 59
Fine-needle aspiration biopsy
of thyroid gland: Sec. 3, Ch. 33
Fistula
vesicoenteric: Sec. 3, Ch. 56; Sec. 3, Ch. 56
vesicovaginal: Sec. 3, Ch. 56; Sec. 3, Ch. 56
Flapping tremor: Sec. 3, Ch. 30
Flashing lights
in diabetic retinopathy: Sec. 3, Ch. 36
Flecainide: Sec. 3, Ch. 47
Floaters
in diabetic retinopathy: Sec. 3, Ch. 36
Flu: (see Influenza)
Fludrocortisone: Sec. 3, Ch. 30
Fluid therapy
in dehydration: Sec. 3, Ch. 39
in diarrhea: Sec. 3, Ch. 55
in fainting prevention: Sec. 3, Ch. 20
for high calcium levels: Sec. 3, Ch. 18
in hyperthermia: Sec. 3, Ch. 19
shortness of breath and: Sec. 2, Ch. 16
Fluid(s): (see also Water)
around heart (pericardial effusion): Sec. 3, Ch. 44; Sec. 3 Ch. 46 [detail]
     in lung cancer: Sec. 3, Ch. 51
around lung (pleural effusion)
     in lung cancer: Sec. 3, Ch. 51
body
     loss of: (see Dehydration)
     postsurgical imbalance of: Sec. 2, Ch. 12
     tests on: Sec. 2, Ch. 10
retention of: (see Swelling [edema])
Fluorescein angiography: Sec. 3, Ch. 36; Sec. 3, Ch. 36; Sec. 3, Ch. 36
Fluoride
supplemental: Sec. 3, Ch. 22
Fluoroscopy
in swallowing difficulty: Sec. 3, Ch. 54
Fluoxetine
in depression: Sec. 3, Ch. 32
St. John's wort interaction with: Sec. 2, Ch. 7
undernutrition and: Sec. 3 Ch. 17 [detail]
Fluphenazine: Sec. 3, Ch. 32
Flurazepam: Sec. 2, Ch. 6; Sec. 2, Ch. 6
urinary incontinence with: Sec. 3, Ch. 57
Flutamide: Sec. 3, Ch. 51
Fluvastatin: Sec. 3, Ch. 44
in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45
Fluvoxamine: Sec. 3, Ch. 32
Folic acid (folate)
in coronary artery disease: Sec. 3, Ch. 45
deficiency of: Sec. 3, Ch. 17; Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3, Ch. 49
Food pyramid: Sec. 2, Ch. 5
Food: (see also Diet; Nutrition)
acid reflux and: Sec. 3, Ch. 54
aspiration of: Sec. 3, Ch. 17; Sec. 3, Ch. 52; Sec. 3, Ch. 54; Sec. 3, Ch. 54
calcium in: Sec. 2, Ch. 5
contamination of: Sec. 3, Ch. 55
empty-calorie: Sec. 2, Ch. 5; Sec. 3, Ch. 17
fat in: Sec. 3, Ch. 44
fats in: Sec. 2, Ch. 5
fiber in: Sec. 2, Ch. 5
in gastroesophageal reflux: Sec. 3, Ch. 54
for healthy diet: Sec. 2, Ch. 4
hospital: Sec. 2, Ch. 11
labels for: Sec. 2, Ch. 5
nutrient content of: Sec. 2, Ch. 5; Sec. 3, Ch. 17
potassium-rich: Sec. 3, Ch. 46
preparation of: Sec. 3, Ch. 17
protein in: Sec. 2, Ch. 5
reflux of: Sec. 3, Ch. 17
regurgitation of: Sec. 3, Ch. 54
rhinitis with: Sec. 3, Ch. 38
serving sizes of: Sec. 2, Ch. 5
in swallowing difficulty: Sec. 3, Ch. 54
swallowing of: (see Swallowing)
taste of: Sec. 1, Ch. 2
tooth loss and: Sec. 3, Ch. 39
vitamin D in: Sec. 2, Ch. 5
Foot (feet)
bunion of: Sec. 3, Ch. 40
calluses of: Sec. 3, Ch. 40
care of: Sec. 3 Ch. 40 [sidebar]; Sec. 3 Ch. 34 [sidebar]
corns of: Sec. 3, Ch. 40
in diabetes mellitus: Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3 Ch. 34 [sidebar]
pain in: Sec. 3, Ch. 40
Foreign objects
in esophagus: Sec. 3, Ch. 54
Forgetfulness: Sec. 3 Ch. 27 [sidebar]
in Alzheimer's disease: Sec. 3, Ch. 27
in dementia: Sec. 3, Ch. 27
Forms
medical history: Sec. 2, Ch. 8
Fosinopril
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Foster Grandparent Program: Sec. 4, Ch. 61
Fountain of youth: Sec. 1, Ch. 1
Fracture: Sec. 3, Ch. 23
bed rest and: Sec. 3, Ch. 23
cast for: Sec. 3, Ch. 23
healing of: Sec. 3, Ch. 23
hip: Sec. 3, Ch. 21; Sec. 3, Ch. 23
     prevention of: Sec. 3, Ch. 21; Sec. 3, Ch. 23
     treatment of: Sec. 3, Ch. 23; Sec. 3, Ch. 23
in osteoporosis: Sec. 3, Ch. 22; Sec. 3, Ch. 22
pins for: Sec. 3, Ch. 23
reduction of: Sec. 3, Ch. 23
shoulder: Sec. 3, Ch. 23
spine (vertebrae): Sec. 3, Ch. 22
surgery for: Sec. 3, Ch. 23
traction for: Sec. 3, Ch. 23
wrist: Sec. 3, Ch. 23; Sec. 3, Ch. 23
Free radicals: Sec. 1, Ch. 1; Sec. 1 Ch. 1 [sidebar]
Fungal infection
at end of life: Sec. 2, Ch. 16
oral: Sec. 3, Ch. 39
pneumonia: Sec. 3, Ch. 52
sinus: Sec. 3, Ch. 38; Sec. 3, Ch. 38
toenail: Sec. 3, Ch. 40
Furosemide: Sec. 3, Ch. 18
dizziness with: Sec. 3, Ch. 20
in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46
urinary incontinence with: Sec. 3, Ch. 57
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.